Picture of Aravive logo

ARAV — Aravive News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Aravive Reports Q3 2022 Financial Results

Nov 10 (Reuters) - Aravive Inc  ARAV.O :
    * ARAVIVE REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS AND
PROVIDES CORPORATE UPDATES
    * REVENUES FOR THREE MONTHS ENDED SEPTEMBER 30, 2022, WERE
ABOUT
$4.9 MILLION, COMPARED TO ABOUT $1.6 MILLION FOR THREE MONTHS
ENDED JUNE 30, 2022
    * QTRLY LOSS PER SHARE $0.51
    * Q3 EARNINGS PER SHARE VIEW $-0.64, REVENUE VIEW $972000.00
--
REFINITIV IBES DATA
    * ARAVIVE - CONTINUED ADVANCEMENT OF CLINICAL TRIALS IN
PLATINUM
RESISTANT OVARIAN CANCER, CLEAR CELL RENAL CELL CARCINOMA,
PANCREATIC ADENOCARCINOMA

Source text for Eikon:  ID:nGNX4p0Mvd 
Further company coverage:  ARAV.O 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Aravive

See all news